Literature DB >> 21087626

Antibiotic resistant mutants of Escherichia coli K12 show increases in heterologous gene expression.

Adnan Ahmetagic1, John M Pemberton.   

Abstract

Using a variety of antibiotics, it was found that nine separate isolates of spontaneous antibiotic resistant mutants of Escherichia coli K12 pPSX-vioABCDE overproduce the anti-tumour antibiotic violacein. Subsequent analysis showed that seven of these mutations occurred on the plasmid pPSX-vioABCDE. The other two overproducing strains carried spontaneous chromosomal mutations to lincomycin and kanamycin. The kanamycin resistant mutant of E. coli K12 DH10B (AA23) and a lincomycin resistant mutant of E. coli K12 LE392 (AA24) increased the synthesis of violacein. The plasmid pPSX-vioABCDE opv-1 contains a violacein over-production (opv-1) mutation which when introduced into either E. coli K12 AA23 or AA24, resulted in a hyper-production of violacein. Remarkably, E. coli K12 AA23 pPSX-vioABCDE opv-1 produced 41 times the normal level of violacein. In addition, both E. coli K12 AA23 and E. coli K12 AA24 demonstrated an increase in expression of an alpha amylase gene from Streptomyces lividans and the urease gene cluster from Klebsiella oxytoca. These results suggest that selection of antibiotic resistant mutants can increase heterologous gene expression in E. coli K12. Additionally, the increased expression is a general effect applicable to genes and gene clusters cloned into E. coli K12 from both Gram-positive and Gram-negative bacteria. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087626     DOI: 10.1016/j.plasmid.2010.11.004

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  4 in total

1.  Functional characterization of a novel violacein biosynthesis operon from Janthinobacterium sp. B9-8.

Authors:  Xian Xu; Xiaoting Chu; Bangmian Du; Chunyan Huang; Chengjia Xie; Zhidong Zhang; Ling Jiang
Journal:  Appl Microbiol Biotechnol       Date:  2022-04-21       Impact factor: 4.813

Review 2.  New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters.

Authors:  Kozo Ochi; Takeshi Hosaka
Journal:  Appl Microbiol Biotechnol       Date:  2012-11-11       Impact factor: 4.813

3.  Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.

Authors:  Gabriel G Perron; R Fredrik Inglis; Pleuni S Pennings; Sarah Cobey
Journal:  Evol Appl       Date:  2015-03-23       Impact factor: 5.183

Review 4.  The Application of Ribosome Engineering to Natural Product Discovery and Yield Improvement in Streptomyces.

Authors:  Saibin Zhu; Yanwen Duan; Yong Huang
Journal:  Antibiotics (Basel)       Date:  2019-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.